ENTRY       D05349                      Drug
NAME        Pancrelipase (JAN/USP);
            Cotazym (TN);
            Creon (TN);
            Pancrease (TN);
            Zenpep (TN)
PRODUCT     CREON (AbbVie)
            PANCREAZE (VIVUS LLC)
            PERTZYE (Digestive Care)
            VIOKACE (Nestle Healthcare Nutrition)
            ZENPEP (Nestle Healthcare Nutrition)
REMARK      Therapeutic category: 2331
            Product: D05349<JP/US>
EFFICACY    Digestant adjunct (enzyme)
  DISEASE   Cystic fibrosis [DS:H00218]
            Chronic pancreatitis [DS:H01680]
BRITE       USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Pancrelipase
               D05349  Pancrelipase (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               233  Stomachics and digestives
                2331  Digestive enzymes
                 D05349  Pancrelipase (JAN/USP)
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05349
DBLINKS     CAS: 53608-75-6
            PubChem: 47207034
///
